JPS61242594A - Reagent kit for determination of enzymatic activity - Google Patents

Reagent kit for determination of enzymatic activity

Info

Publication number
JPS61242594A
JPS61242594A JP8503985A JP8503985A JPS61242594A JP S61242594 A JPS61242594 A JP S61242594A JP 8503985 A JP8503985 A JP 8503985A JP 8503985 A JP8503985 A JP 8503985A JP S61242594 A JPS61242594 A JP S61242594A
Authority
JP
Japan
Prior art keywords
reagent
group
substrate
coupler
oxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8503985A
Other languages
Japanese (ja)
Other versions
JPH0573399B2 (en
Inventor
Yuzo Hayashi
林 勇藏
Noboru Mitsuhida
光飛田 登
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd filed Critical Toyobo Co Ltd
Priority to JP8503985A priority Critical patent/JPS61242594A/en
Publication of JPS61242594A publication Critical patent/JPS61242594A/en
Publication of JPH0573399B2 publication Critical patent/JPH0573399B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To provide a reagent kit for the determination of enzymatic activity, consisting of the first reagent containing a specific substrate and a coupler and the second reagent containing an oxidase, capable of determining the activity under mild reaction condition in excellent operability, simplicity and accuracy, having high storage stability, and applicable to initial rate process. CONSTITUTION:The objective reagent kit for the determination of enzymatic activity consists of the first reagent and the second reagent. The second reagent contains an oxidase. The first reagent contains the substrate of formula (Xm is peptide residue composed of m amino acid residues bonded together wherein the C-terminal amino acid forms amide bond with the amino group bonded to the aromatic group; A is group protecting the N-terminal of the peptide residue or H atom; m is 1-10; Z is H, halogen, lower alkyl, etc.; n is 1-5) and a coupler and/or a chelating agent. The pH of the first reagent is <=5.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は酵素活性測定用試薬キットに関するものである
DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a reagent kit for measuring enzyme activity.

本発明の対象となる酵素とはペプチド結合加水分解酵素
であり、例えばロイシンアミノベプテダーゼ、γ−グル
タミルトランスベプチターゼ、シスチンアミノペプチダ
ーゼの様な各種(アミノ)ペプチダーゼやトリプシン、
α−キモトリプシン。
The enzymes targeted by the present invention are peptide bond hydrolases, such as various (amino)peptidases such as leucine aminopeptidase, γ-glutamyl transpeptidase, cystine aminopeptidase, trypsin,
α-Chymotrypsin.

プラスミン、トロンビン、カリクレイン、ウロキナーゼ
、エンドトキシン、第Xa因子、コラゲナーゼ、エラス
ターゼ、カテプシンの様な各種プロテアーゼ等が挙げら
れる。体液中のとnら各種加水分解酵素活性の測定は有
用な診断情報を与えるものとして臨床的意義が高い。
Examples include various proteases such as plasmin, thrombin, kallikrein, urokinase, endotoxin, factor Xa, collagenase, elastase, and cathepsin. Measurement of the activity of various hydrolytic enzymes such as Ton et al. in body fluids is of great clinical significance as it provides useful diagnostic information.

(従来の技術) 従来のこれら加水分解酵素の測定法としては、例えばγ
−グルタミルトランスペプチターゼ(r−GTP)活性
測定によく利用されているアミン化合物をメタ過ヨード
酸により適当なカプラーと酸化縮合させ比色定量をする
方法(例えば高林利行他、臨床病理(補)29 、p5
38(1979))、あるいはロイシンアミノペプチダ
ーゼ(LAP)活性測定でみられるアミン化合物を亜硝
酸塩でジアゾ化して適当なカプラーとカップリングさせ
、その後比色定量する方法(例えばJ 、A 、Gol
dbarg 、 Ca−ncer II 、 p 28
3 (1958))などの化学的な方法による比色定量
法がある。ところが化学的酸化剤(例えば7エリシアン
化カリ、メタ過ヨード酸)や亜硝酸塩を用いるジアゾカ
ップリング法を用いる化学的な方法では目的とする酵素
活性は、目的とする酵素の反応条件と検出して利用され
る酸化反応やジアゾカップリング反応条件が異なること
や、検出反応として利用される酸化剤やジアゾ化剤が目
的とする酵素を阻害する点などにより、検出反応と同時
同一の反応条件下で検出するととが出来彦い為に操作段
階が多く、測定時間も長く、全体に測定が繁雑となる。
(Prior art) Conventional methods for measuring these hydrolytic enzymes include, for example, γ
- A method of colorimetric determination by oxidative condensation of an amine compound with a suitable coupler using metaperiodic acid, which is often used to measure glutamyl transpeptidase (r-GTP) activity (for example, Toshiyuki Takabayashi et al., Clinical Pathology (Supplementary)) 29, p5
38 (1979)), or a method in which the amine compound found in the measurement of leucine aminopeptidase (LAP) activity is diazotized with nitrite and coupled with an appropriate coupler, followed by colorimetric determination (e.g. J, A, Gol
dbarg, Ca-ncer II, p 28
There are colorimetric methods using chemical methods such as 3 (1958)). However, in chemical methods using diazo coupling methods using chemical oxidizing agents (e.g., potassium hepterythyanide, metaperiodic acid) and nitrite, the desired enzyme activity cannot be detected according to the reaction conditions of the desired enzyme. The oxidation reaction and diazo coupling reaction conditions used in the detection reaction are different, and the oxidizing agent and diazotization agent used in the detection reaction inhibit the target enzyme. Since detection is difficult, there are many operating steps, the measurement time is long, and the overall measurement is complicated.

又フェリシアン化カリウムの様な有害な薬品を使用する
点や塩酸酸性下でのジアゾ化反応の様に苛酷な反応条件
が必要な点で問題がある。
Further, there are problems in that harmful chemicals such as potassium ferricyanide are used and harsh reaction conditions are required such as the diazotization reaction under acidic conditions with hydrochloric acid.

また最近、酵素法(特開昭59−88099号)が提案
されている。つまりLAP又はγ−GTPの基質として
アニリン誘導体を用いて酵素の働きで遊離したアニリン
化合物をカップラーの存在下、ラッカーゼ、アスコ兵ビ
ン酸オキシダーゼ、チロシナーゼ等の酸化酵素で発色さ
せ、その吸光度の変化により加水分解酵素活性を求める
ものであり、従来の化学法のもつ初速度測定が出来ない
欠点をなくした測定法で、酵素活性測定法として優れて
いる。しかし、この方法では基質、カップラー、酸化酵
素を含む反応液の安定性が悪い。またその為に使用出来
るカップラー、基質、酸化酵素に制限があり、実用出来
る範囲が狭いものにならざるを得なかった。例えばカッ
プラーや基質としては保存安定性の劣化を防ぐ為に比較
的酸化反応の低い化合物が選らばれなければならない。
Recently, an enzymatic method (Japanese Unexamined Patent Publication No. 59-88099) has been proposed. In other words, using an aniline derivative as a substrate for LAP or γ-GTP, the aniline compound liberated by the action of an enzyme is colored with an oxidizing enzyme such as laccase, ascorbate oxidase, or tyrosinase in the presence of a coupler, and the change in absorbance is This method measures hydrolytic enzyme activity, and is an excellent method for measuring enzyme activity since it eliminates the drawback of conventional chemical methods, which cannot measure initial velocity. However, in this method, the stability of the reaction solution containing the substrate, coupler, and oxidase is poor. Moreover, there are restrictions on the couplers, substrates, and oxidizing enzymes that can be used for this purpose, which inevitably limits the range of practical applications. For example, compounds with relatively low oxidation reactions must be selected as couplers and substrates to prevent deterioration of storage stability.

その結果測定に必要な感度が十分得られない欠点がある
。又使用される酸化酵素も比較的酸化縮合反応能の低い
ものを使用しないとカップラーの劣化を生じさせる為に
酸化反応能の高い酸化酵素が使用出来ないという制約も
あった。
As a result, there is a drawback that sufficient sensitivity required for measurement cannot be obtained. There is also a restriction that an oxidizing enzyme having a relatively low oxidative condensation reaction ability may cause deterioration of the coupler, and therefore an oxidizing enzyme having a high oxidizing reaction ability cannot be used.

(問題を解決する為の手段) 本発明者等はかかる従来の欠点を解消し、温和な反応条
件下で操作性、簡便性の優れた正確度の高い、しかも保
存安定性の良い初速変法が可能な酵素活性測定法を見い
出すべく種々鋭意検討した結果、本発明に到達した。す
なわち本発明は下記一般式〔I〕で表わさnる基質およ
びカプラーを含み、さらにpH5以下であり、および/
又はキレート剤を含む第一試薬と酸化酵素を含む第二試
薬からなることを特徴とする酵素活性測定用試薬キラ(
式中、Xmは同じか又は異なったアミノ酸がm個結合し
たペプチド残基を示し、C末端のアミノ酸は芳香族基に
結合したアミノ基とアミド結合を形成している。Aは上
記ペプチド残基のN末端を保護する基又は水素原子を示
す、。m=1〜10である。2は水素原子、ハロゲン原
子、低級アルキル基、低級アルコキシル基、アミン基、
水酸基、カルボニル基、スルホン酸基、置換アミノ基を
示し、n=1〜5である。複数のZは同じでも異なって
いてもよく、又置換基−NH−のオルト位とメタ位で環
を形成する基であってもよい。)本発明では一般式〔■
〕で表わされる基質が酵素反応の結果、下記一般式(’
10で表わされる遊離アニリン誘導体を生じ、この遊離
アニリン誘導体をカプラーの共存下、酸化酵素と作用さ
せて酸化縮合物を得、その分光学的な吸光度の変化を測
定するか、又は酸化酵素により消費される酸素を酸素電
極等で測定することにより、酵素活性を測定す(式中、
Zは水素原子、ハロゲン原子、低級アルキル基、低級ア
ルコキシル基、アミノ基、水酸基、カルボキシル基、ス
ルホン酸基、置換アミノ基を示し、n−1〜5である。
(Means for Solving the Problem) The present inventors have solved such conventional drawbacks, and have developed a modified initial velocity method that is easy to operate, easy to use, highly accurate, and has good storage stability under mild reaction conditions. The present invention was achieved as a result of various intensive studies to find a method for measuring enzyme activity that would allow the following. That is, the present invention includes a substrate and a coupler represented by the following general formula [I], and further has a pH of 5 or less, and/
Or, a reagent for enzyme activity measurement, CHILA (
In the formula, Xm represents a peptide residue in which m pieces of the same or different amino acids are bonded, and the C-terminal amino acid forms an amide bond with the amino group bonded to the aromatic group. A represents a group or hydrogen atom that protects the N-terminus of the peptide residue. m=1 to 10. 2 is a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxyl group, an amine group,
It represents a hydroxyl group, a carbonyl group, a sulfonic acid group, or a substituted amino group, and n=1 to 5. A plurality of Z may be the same or different, and may be a group forming a ring at the ortho position and meta position of the substituent -NH-. ) In the present invention, the general formula [■
] As a result of the enzymatic reaction, the substrate represented by the following general formula ('
A free aniline derivative represented by 10 is produced, and this free aniline derivative is reacted with an oxidase in the presence of a coupler to obtain an oxidized condensate, and the change in spectroscopic absorbance thereof is measured or consumed by the oxidase. Enzyme activity is measured by measuring the oxygen produced using an oxygen electrode, etc. (in the formula,
Z represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxyl group, an amino group, a hydroxyl group, a carboxyl group, a sulfonic acid group, or a substituted amino group, and is n-1 to n-5.

複数の2は同じでも異なっていてもよく、また置換基−
NHl  のオルト位とメタ位で環を形成する基であっ
てもよい。)本発明の第一試薬は一般式〔I〕で表わさ
れる基質およびカプラーを含み、さらにpH5以下であ
るか又はキレート剤を含むか、又はpH5以下であって
、かつキレート剤を含む。
A plurality of 2's may be the same or different, and a substituent -
It may also be a group that forms a ring at the ortho and meta positions of NHL. ) The first reagent of the present invention contains a substrate represented by general formula [I] and a coupler, and further has a pH of 5 or less or contains a chelating agent, or has a pH of 5 or less and contains a chelating agent.

一般式〔I〕で表わされる基質とは先に説明した遊離ア
= IJン誘導体〔■〕を構成成分としてもつ化合物で
あり、かつ各種ペプチダーゼ、各種プロテアーゼの様な
ペプチド結合加水分解酵素が作用する基質であれば、い
かなるものでも良い。例えば基質〔■〕の基A−Xmと
しては、ロイシンアミノペプチダーゼの基質となるL−
ロイシル基、γ−グルタミルトランスペプチダーゼの基
質となるγ−L−グルタミル基、シスチンアミノペプチ
ダーゼの基質となるS−ベンジル−L−システニル基、
X−プロリル−ジペプチジル−アミノペプチダーゼの基
質となるグリシル−L−プロリル基、トロンビンの基質
となる Bz −phe −Val −Arg −(Bz :ベ
ンゾイル基)Tos −G ly −Pro −Arg
   (Tos : )シル基)Boa −Val −
Pro −Arg −(BoCst−ブトキシカルボニ
ル基) H−D −Pro −Arg −、H−D−Phe−P
ip −Arg −プラスミンの基質となる Tos −017−Pro−Arg −Boc −Gl
u −Lys −Ly8−Boc −Vat −Leu
−Ly8−H−D−Val −Leu −Lys −ウ
ロキナーゼの基質となる Bz −Val −Gly −Arg −Pyro −
Glu−GlyArg −G 1utaryl −Gl
y−Arg −カリクレインの基質となる Bz −Pro −Phe −Arg −H−D −P
ro −Phe −Arg −Z −Phe −Arg
 −(Z :カーポベンゾイル基)H−D−Val −
Leu−Arg −pro −Phe −Arg − 第Xa因子の基質となる Bz −11e −Glu −Gly−Arg−−Bo
c−11e−Glu−Gly−Arg−エンドトキシン
の検出に利用さnる基質となるBoc −Leu − Boc−Vat−Leu − Boc−8er− Boc−Vat−8er − Bz−Leu− Bz −Val −Lyeu − Bz−8er− Bz−Val−8er − 等があげられる。
The substrate represented by the general formula [I] is a compound having the above-mentioned free α-IJ derivative [■] as a constituent, and on which peptide bond hydrolases such as various peptidases and various proteases act. Any substrate may be used as long as it is a substrate. For example, the group A-Xm of the substrate [■] is L-, which is the substrate of leucine aminopeptidase.
leucyl group, a γ-L-glutamyl group that is a substrate for γ-glutamyl transpeptidase, an S-benzyl-L-cystenyl group that is a substrate for cystine aminopeptidase,
Glycyl-L-prolyl group serving as a substrate for X-prolyl-dipeptidyl-aminopeptidase, Bz-phe-Val-Arg-(Bz: benzoyl group) Tos-Gly-Pro-Arg serving as a substrate for thrombin
(Tos: ) syl group) Boa -Val -
Pro -Arg - (BoCst-butoxycarbonyl group) HD -Pro -Arg -, HD-Phe-P
ip -Arg -Tos -017-Pro-Arg -Boc -Gl, which is a substrate for plasmin
u -Lys -Ly8-Boc -Vat -Leu
-Ly8-H-D-Val -Leu -Lys -Bz -Val -Gly -Arg -Pyro - which is a substrate of urokinase
Glu-GlyArg-G1utaryl-Gl
y-Arg -Bz-Pro-Phe-Arg-H-D-P, which is a substrate for kallikrein
ro -Phe -Arg -Z -Phe -Arg
-(Z: carpobenzoyl group)HD-Val-
Leu-Arg -pro -Phe -Arg - Bz -11e -Glu -Gly-Arg--Bo, which is a substrate for factor Xa
c-11e-Glu-Gly-Arg-Boc-Leu-Boc-Vat-Leu-Boc-8er-Boc-Vat-8er-Bz-Leu-Bz-Val-Lyeu as a substrate used for detection of endotoxin - Bz-8er- Bz-Val-8er - etc.

次に使用されるカプラーとしては、一般式〔■〕で示さ
れる化合物を基質として用い、酵素反応の結果、生じた
遊離アニリン誘導体[11)で表わされる化合物と酸化
縮合して新たな吸収をもつ化合物を形成するものであれ
ば、いかなるものでもよい。
The coupler to be used next uses the compound represented by the general formula [■] as a substrate and undergoes oxidative condensation with the compound represented by the free aniline derivative [11] generated as a result of the enzymatic reaction, resulting in a new absorption property. Any substance may be used as long as it forms a compound.

例えばp−キシレノール、p−クロロフェノール3.5
−ジクロロフェノールスルホン酸、3−ノ1イドロキシ
−2,4,6−)リョード安息香酸の様なフェノール誘
導体やN、N−ジメチルアニリン、N、N−一〇− ジエチルアニリン、N、N−ジエチル−m−)ロイシン
、N−エチル−N−(3−スルホプロピル) −m−7
ニシジン、N−エチル−N−(2−ヒト胃キシー3−ス
ルホプロピル)−m−トルイジン、3−メチル−N−エ
チル−N−(2−ヒドロキシエチル)−アニリン、N−
エチル−N−(3−)チルフェニル)−N−サクシニル
エチレンジアミン、N−エチル−N−(3−メチルツボ
ニル)−N−アセチルエチレンジアミン、N−エチル−
N−スルホプロピル−m−トルイジン、N−エチル−N
−(β−メチルスルホンアミドエチル)−m−)ロイシ
ンの様なアニリン誘導体や1−ナフトール−2−スルホ
ン酸の様なナフトール誘導体等が挙げられる。次に遊離
アニリン誘導体〔■〕としては各種ペプチダーゼや各種
プロテアーゼの様な各種加水分解酵素が作用して化合物
CIDく を遊離して念る様な上記加水分解酵素の基質mとなる化
合物の構成成分である化合物[川であれぽいかなる化合
物でも良い。例えば4−アミノ−N−エチル−N−(β
−メタンスルホンアミドエチル)−m−トルイジン、4
−アミノ−3−メチル−N−(β−ヒドロキシエチル)
−N−エチルアニリン、p−N−エテル−N−ヒドロギ
シエチルアニリン、2−アミノ−5−ジエチルアミノト
ルエン、p−モルフォリノアニリン、p−N、N−ジス
ルホプロピルアミノアニリン、p−N、N−ジエチルア
ミンアニリン、β−ナフチルアミン、α−ナフチルアミ
ン、3−カルボキシ−4−ヒドロキシアニリン、3−カ
ルボキシ−4−N、N−ジ−n−プロピルアミノアニリ
ン等の化合物が挙げられる。
For example, p-xylenol, p-chlorophenol 3.5
- Phenol derivatives such as dichlorophenolsulfonic acid, 3-hydroxy-2,4,6-)ryodobenzoic acid, N,N-dimethylaniline, N,N-10-diethylaniline, N,N-diethyl -m-) Leucine, N-ethyl-N-(3-sulfopropyl) -m-7
Nisidine, N-ethyl-N-(2-human gastric xy-3-sulfopropyl)-m-toluidine, 3-methyl-N-ethyl-N-(2-hydroxyethyl)-aniline, N-
Ethyl-N-(3-tylphenyl)-N-succinylethylenediamine, N-ethyl-N-(3-methyltubonyl)-N-acetylethylenediamine, N-ethyl-
N-sulfopropyl-m-toluidine, N-ethyl-N
Examples include aniline derivatives such as -(β-methylsulfonamidoethyl)-m-)leucine and naphthol derivatives such as 1-naphthol-2-sulfonic acid. Next, as free aniline derivatives [■], various hydrolases such as various peptidases and various proteases act to liberate the compound CID, which is a component of the compound that becomes the substrate m of the above-mentioned hydrolase. A compound that is a river [any compound is fine, even if it is a river]. For example, 4-amino-N-ethyl-N-(β
-methanesulfonamidoethyl)-m-toluidine, 4
-amino-3-methyl-N-(β-hydroxyethyl)
-N-ethylaniline, p-N-ethyl-N-hydroxyethylaniline, 2-amino-5-diethylaminotoluene, p-morpholinoaniline, p-N, N-disulfopropylaminoaniline, p-N, Compounds such as N-diethylamine aniline, β-naphthylamine, α-naphthylamine, 3-carboxy-4-hydroxyaniline, 3-carboxy-4-N, and N-di-n-propylaminoaniline are mentioned.

本発明に用いるキレート剤としては、一般的な金属キレ
ート化剤が使用され、金属イオンを捕捉して不活性化で
きるものである限り、その種類は問わないが、代表的な
ものとしてはエチレンジアミン四酢酸並びにその塩が例
示される。
As the chelating agent used in the present invention, a general metal chelating agent is used, and the type is not limited as long as it can capture and inactivate metal ions, but a typical example is ethylenediamine tetra. Examples include acetic acid and its salts.

本発明の第二試薬は酸化酵素を含む。The second reagent of the invention contains an oxidase.

本発明において使用する酸化酵素としては、反応におい
て少なくとも酸素を消費して新たな吸収を示す酸化縮合
物を生成する酸化酵素であれば特に限定しない。このよ
うな酵素としては例えばラッカーゼ、ビリルビンオキシ
ダーゼ、ポリフズノールオキシダーゼ、チロシナーゼ、
アスコルビン酸オキシダーゼ、アミンフェノールオキシ
ダーゼなどが挙げられる。その起源とL4け例えばラッ
カーゼとしてはウルシやコリオラス(Coriolus
 )属赳のもの(特開昭58−47489号公報)があ
り、またビリ、ルピンオキシダーゼとしてはミロセシウ
ム(M)’rothec ium )属由来(Agri
c、 Biol、 Chern。
The oxidase used in the present invention is not particularly limited as long as it consumes at least oxygen in the reaction and produces an oxidized condensate that exhibits new absorption. Such enzymes include, for example, laccase, bilirubin oxidase, polyfusunol oxidase, tyrosinase,
Examples include ascorbic acid oxidase and amine phenol oxidase. Its origin and L4 enzymes, such as laccase, are found in sumac and Coriolus.
) (Japanese Unexamined Patent Publication No. 58-47489), and lupine oxidase derived from the genus Myrocesium (M)'rothecium (Agri).
c, Biol, Chern.

45、2383 (1981) )のものがあり、また
アスコルビン酸オキシダーゼとしてはカポチャやキュウ
リ由来のもの(特開昭56−88793号公報)が挙げ
られる。
45, 2383 (1981)), and examples of ascorbic acid oxidase include those derived from kapocha and cucumber (Japanese Unexamined Patent Publication No. 56-88793).

本発明の第一試薬および第二試薬には、測定する酵素の
種類に応じて必要な物質例えばアミノ酸やペプチド等が
含ま扛ている。測定する酵素が例えばγ−グルタミルト
ランスペプチダーゼの場合には、第−試薬寸たは第二試
薬にはグリシルグリシンが適尚量含まれている。
The first reagent and second reagent of the present invention contain necessary substances such as amino acids and peptides depending on the type of enzyme to be measured. When the enzyme to be measured is, for example, γ-glutamyl transpeptidase, the first reagent or the second reagent contains an appropriate amount of glycylglycine.

本発明の試薬キットは一般式CI)で表わされる基質お
よびカプラーを含み、さらにpH5以下であるか、又は
キレート剤を含むか、又はpH5以下であってキレート
剤を含む試薬を第一試薬とし、酸化酵素を含む試薬を第
二試薬とする。
The reagent kit of the present invention includes a substrate and a coupler represented by the general formula CI), and further has a pH of 5 or less, or contains a chelating agent, or has a reagent that has a pH of 5 or less and contains a chelating agent as a first reagent, A reagent containing an oxidizing enzyme is used as a second reagent.

第一試薬がカプラーを含有せずに、第二試薬がカプラー
を含有するとブランク値が向上して好ましくない。また
第一試薬がカプラーを含んでいてもpHが5以下または
キレート剤を含有していないとブランク値の上昇がみら
れる。
If the first reagent does not contain a coupler and the second reagent contains a coupler, the blank value will increase, which is not preferable. Furthermore, even if the first reagent contains a coupler, if the pH is 5 or less or if it does not contain a chelating agent, the blank value will increase.

本発明の酵素活性測定用試薬キットは上記第一試薬と上
記第二試薬とからなり、プ四テアーゼ活性を測定するに
は、例えば血清あるいは尿等の被検液に第二試薬を加え
、約37℃に予備加温し、続いて第一試薬を加えるか又
は第一試薬を添加後に第二試薬を加えてもよい。また第
一試薬と第二試薬を同時に被検液に加えてもよい。さら
に本発明の第一試薬に第二試薬と被検液を加えてもよい
The reagent kit for enzyme activity measurement of the present invention consists of the above-mentioned first reagent and the above-mentioned second reagent, and in order to measure the tetratease activity, the second reagent is added to a test liquid such as serum or urine, and approximately The first reagent may be prewarmed to 37° C. and then the first reagent added, or the second reagent may be added after the first reagent is added. Alternatively, the first reagent and the second reagent may be added to the test liquid at the same time. Furthermore, a second reagent and a test liquid may be added to the first reagent of the present invention.

上記試薬を作用させる条件としては特に限定はないが、
被検液中の加水分解酵素が作用する条件のpHを保つ緩
衝液を使用することが多い。4通常はpH5,0〜10
.0に保つ様な緩衝液が用いられる。
There are no particular limitations on the conditions under which the above reagents are allowed to act, but
A buffer solution is often used that maintains the pH conditions under which the hydrolase in the test solution acts. 4 Usually pH 5.0-10
.. A buffer solution that maintains the temperature at 0 is used.

次に酸化酵素の使用量は加水分解酵素反応を追跡するに
十分な量であれば特に限定はない。例えば反応液1−当
り0.1〜100単位もあれば十分である。カプラーの
濃度としては遊離してくるアニリン誘導体〔■〕に対し
て等モル以上を用いればよく、場合によっては上限とし
て目的とする加水分解酵素活性を阻害しない程度の量と
なる。
Next, the amount of oxidase used is not particularly limited as long as it is sufficient to monitor the hydrolase reaction. For example, 0.1 to 100 units per reaction solution is sufficient. The concentration of the coupler may be at least equimolar to the liberated aniline derivative [■], and in some cases, the upper limit may be an amount that does not inhibit the desired hydrolase activity.

次に基質濃度としては目的とする加水分解酵素活性を十
分に発揮させる濃度であればよく、場合によっては上限
として加水分解酵素が基質阻害を受けない程度の量とな
る。次に金属キレート剤の濃度としては特に制限はない
が通常は0.1〜100mM程度であれば十分である。
Next, the substrate concentration may be any concentration that sufficiently exhibits the desired hydrolase activity, and in some cases, the upper limit may be such that the hydrolase is not inhibited by the substrate. Next, the concentration of the metal chelating agent is not particularly limited, but usually a concentration of about 0.1 to 100 mM is sufficient.

次に基質及びカプラー又は酸化酵素及びカプラーを含む
試薬をI)H5,0以下に保つ方法は、それを構成する
成分の安定性に影響を与えないものであればいかなる組
成、方法でもよい。
Next, the method for maintaining the substrate and coupler or the reagent containing the oxidizing enzyme and coupler at I) H5,0 or lower may be any composition and method as long as it does not affect the stability of the constituent components.

反応温度としては通常臨床化学分析に利用さnる温度、
例えば20〜50℃の範囲で行えば良い。
The reaction temperature is the temperature normally used for clinical chemistry analysis.
For example, it may be carried out at a temperature of 20 to 50°C.

本発明では酸化酵素を作用させた後の定量を生成してく
る酸化縮合物の分光学的な吸光度の変化を測定するか、
又は酸化酵素により消費される酸素を酸素電極等で測定
するかして対応する加水分解酵素活性を求める。
In the present invention, the change in spectroscopic absorbance of the oxidized condensate produced after the action of an oxidase is measured, or
Alternatively, the corresponding hydrolase activity is determined by measuring the oxygen consumed by the oxidase using an oxygen electrode or the like.

(発明の効果) 本発明の試薬キットを用いると温和な条件下で操作性、
簡便性に優れた正確度の高い、しかも保存安定性の良い
初速変法が可能な化合物〔I〕を基質とする加水分解酵
素活性の定翔・が可能となり、臨床検査の診断分野にと
って極めて有意義なものとなる。
(Effect of the invention) Using the reagent kit of the present invention, it is easy to operate under mild conditions.
It is possible to determine the hydrolase activity using compound [I] as a substrate, which is simple and highly accurate, and allows for a modified initial velocity method with good storage stability, and is extremely meaningful for the diagnostic field of clinical testing. Become something.

(実施例) 以下実施例により本発明を説明する。(Example) The present invention will be explained below with reference to Examples.

実施例1 下記試薬組成を有し、試薬構成が第1表で示される試薬
キットA1〜7を用いて、試薬ブランク及びγ−グルタ
ミルトランスフXラーゼ(γ−GTP)活性を測定し、
その結果を第2表に示す。
Example 1 A reagent blank and γ-glutamyl transfer
The results are shown in Table 2.

基  質;L−γ−グルタミルーp−ジエチルア建ノア
ニリド(和光紬薬り5mM Gly−Gly ;グリシルグリシン (牛丼化学薬品製)    100mMカプラー;ジエ
チルアニリン(和光紬薬製)1mMキレート剤; ED
TA−2Na 緩衝液;トリス−i(CA緩衝液(pH7,5) 10
0mM第  1  表 B、測定法 サンプル50μlにm1表の試薬R1を2.Od加え、
37℃で予備加温し、続いて試薬R3を0.5−加えた
後、波長745龍での1分間当りの吸光度の増加を測定
し、γ−GTP活性(ΔOD/m in )とする。又
テンプルの代わりに水50μlを力Uえて上記と同様試
薬R1試薬R1を加え、波長745闘で吸光度を測定し
たものをブランク値とする。
Substrate; L-γ-glutamyl-p-diethylanoanilide (Wako Tsumugi Pharmaceutical Co., Ltd. 5mM Gly-Gly; glycylglycine (Gyudon Chemical Co., Ltd.) 100mM coupler; diethylaniline (Wako Tsumugi Co., Ltd.) 1mM chelating agent; ED
TA-2Na buffer; Tris-i (CA buffer (pH 7,5) 10
0mM Table 1 B, Assay method Add 2.0ml of reagent R1 from Table 1 to 50μl of the sample. Add Od,
After prewarming at 37° C. and subsequently adding 0.5 μm of reagent R3, the increase in absorbance per minute at a wavelength of 745 was measured and defined as γ-GTP activity (ΔOD/min). Also, add 50 μl of water instead of the temple, add reagent R1 in the same manner as above, and measure the absorbance at a wavelength of 745 cm, which is used as a blank value.

第2表 第2表から明らかなように試薬キラ)Al、2は調製直
後の吸光度が高くて実用不可能、A3゜4はl製時は使
用可能であるが、保存中に試薬ブランクが上昇し、r−
GTP活性値も低値を示し試薬の劣化を示している。し
かしA 5* 6e 7は問題なく使用可能である。
As is clear from Table 2, reagent Kira) Al, 2 has a high absorbance immediately after preparation and is not practical, and A3゜4 can be used when it is manufactured, but the reagent blank increases during storage. , r-
The GTP activity value also showed a low value, indicating deterioration of the reagent. However, A5*6e7 can be used without any problem.

実施例2 下記試薬組成をもつγ−GTP測定用試薬キットを用い
、既知濃度の検体を分析した結果を第1図に示す。
Example 2 FIG. 1 shows the results of analyzing a sample with a known concentration using a reagent kit for measuring γ-GTP having the following reagent composition.

A、試薬組成 R,0,1M)リス−塩酸緩衝液 (pH7,5)グリ
シルグリシン   100mM ラッカーゼ      51m・/d RI  HCA          10mMEDTA
  2Na      1mML−γ−グルタミルーp
−ジエチル 5mMアミノアネト ジエチルアニリン   1mM B、測定法 既知検体50μlに試薬島を2.Od加え、37℃で予
備加温し、次いで試薬R,0,54加えた後、波長74
5朋で反応の直線部の1分間歯シの吸光度の変化を測定
する。
A, Reagent composition R, 0.1M) Lis-hydrochloric acid buffer (pH 7.5) Glycylglycine 100mM Laccase 51m/d RI HCA 10mM EDTA
2Na 1mML-γ-glutamylp
-Diethyl 5mM aminoanetodiethylaniline 1mM B, 2. After adding Od and prewarming at 37°C, then adding reagent R, 0,54, wavelength 74
5. Measure the change in absorbance of the tooth for 1 minute during the linear part of the reaction.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の試薬キットを用い、γ−GTPを測定
した場合の検量線を示す。
FIG. 1 shows a calibration curve when γ-GTP was measured using the reagent kit of the present invention.

Claims (1)

【特許請求の範囲】 下記一般式〔 I 〕で表わされる基質およびカプラーを
含み、さらにpH5以下であり、および/又はキレート
剤を含む第一試薬と酸化酵素を含む第二試薬からなるこ
とを特徴とする酵素活性測定用試薬キット。 ▲数式、化学式、表等があります▼〔 I 〕 (式中、X_mは同じか又は異なったアミノ酸がm個結
合したペプチド残基を示し、C末端のアミノ酸は芳香族
基に結合したアミノ基とアミド結合を形成している。A
は上記ペプチド残基のN末端を保護する基又は水素原子
を示す。m=1〜10である。Zは水素原子、ハロゲン
原子、低級アルキル基、低級アルコキシル基、アミノ基
、水酸基、カルボニル基、スルホン酸基、置換アミノ基
を示し、n=1〜5である。複数のZは同じでも異なっ
ていてもよく、又置換基−NH−のオルト位とメタ位で
環を形成する基であってもよい。)
[Claims] A first reagent containing a substrate and a coupler represented by the following general formula [I], having a pH of 5 or less, and/or containing a chelating agent and a second reagent containing an oxidizing enzyme. A reagent kit for measuring enzyme activity. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [I] (In the formula, X_m indicates a peptide residue in which m of the same or different amino acids are bonded, and the C-terminal amino acid is an amino group bonded to an aromatic group. Forms an amide bond.A
represents a group or hydrogen atom that protects the N-terminus of the above peptide residue. m=1 to 10. Z represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxyl group, an amino group, a hydroxyl group, a carbonyl group, a sulfonic acid group, or a substituted amino group, and n=1 to 5. A plurality of Z may be the same or different, and may be a group forming a ring at the ortho position and meta position of the substituent -NH-. )
JP8503985A 1985-04-19 1985-04-19 Reagent kit for determination of enzymatic activity Granted JPS61242594A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8503985A JPS61242594A (en) 1985-04-19 1985-04-19 Reagent kit for determination of enzymatic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8503985A JPS61242594A (en) 1985-04-19 1985-04-19 Reagent kit for determination of enzymatic activity

Publications (2)

Publication Number Publication Date
JPS61242594A true JPS61242594A (en) 1986-10-28
JPH0573399B2 JPH0573399B2 (en) 1993-10-14

Family

ID=13847545

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8503985A Granted JPS61242594A (en) 1985-04-19 1985-04-19 Reagent kit for determination of enzymatic activity

Country Status (1)

Country Link
JP (1) JPS61242594A (en)

Also Published As

Publication number Publication date
JPH0573399B2 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
Thompson et al. A BODIPY fluorescent microplate assay for measuring activity of calpains and other proteases
Lorentz et al. Arylesterase in serum: elaboration and clinical application of a fixed-incubation method.
EP0018112B1 (en) Substrates and method for determining proteolytic enzymes
AU694039B2 (en) Determination of glycated proteins
US4588836A (en) Novel synthetic substrate and assay method using the same
JP2010011876A (en) Method of quantifying glycosylated protein using redox reaction and quantification kit
PL127198B1 (en) Diagnstic agent for determining protheolytic enzymes andmethod of obtaining idoxyl and thioindoxyl esters of amino acids and peptides
JPH0358720B2 (en)
JP2011224025A (en) Method and composition for determination of glycated protein
JP2001057897A (en) Production of fructosylvaline
JP4925384B2 (en) Method for quantifying N-terminal glycated protein
JPS61242594A (en) Reagent kit for determination of enzymatic activity
US7432061B2 (en) Assays for measuring matrix metalloproteinase activities
WO1998005970A1 (en) Method for examining chronic rejection reactions following organ transplantation and method for determining urine components
Trautschold et al. Kallikrein
Brown et al. Determination of carboxypeptidase A using N-acetyl-phenylalanyl-3-thiaphenylalanine as substrate: application to a direct serum assay
CA2286458C (en) Method of detecting procarboxypeptidase a and carboxypeptidase a levels in biological fluids
JPH0775556B2 (en) Fractional quantification method of LDH (1) of LDH isozyme
JP2000189196A (en) Measurement of urea nitrogen and reagent for measuring urea nitrogen
JPH062078B2 (en) Quantitative determination of substrate with bilirubin oxidase
Kuroiwa et al. Determination of alpha 2-macroglobulin-trypsin complex with a new synthetic substrate.
EP0166690B1 (en) Analytical process and means for measuring protease inhibitor capacity of serum
EP0761821A1 (en) Assay method avoiding interference by hemoglobin with light detection
JPS61173799A (en) Method of determining activity of substrate or enzyme
JP2005298632A (en) Method of improvement of stability of reagent